#USA #stem cell #TheWell Bioscience #Monmouth Junction #RocketCell™

TheWell Bioscience Unveils RocketCell™ Cell Viability Enhancer

TheWell Bioscience, a pioneer known for its innovative xeno-free 3D cell culture technologies, has made a remarkable announcement. The launch of RocketCell™ Cell Viability Enhancer marks a significant advancement aimed at improving the recovery, survival, and expansion of cells following critical processes like passaging, cryopreservation, and organoid harvesting. This novel cell recovery reagent is designed not just to increase cell survival but to enhance metabolic activity and proliferation as well.

Cell loss is a formidable challenge faced by researchers in the field of stem cell and organoid research. Traditional methods such as dissociation and cryopreservation often trigger apoptosis, resulting in diminished cell viability and inconsistent results in experiments. RocketCell™ is engineered to tackle these issues head-on, transforming how researchers approach cell culture and ensuring they get the maximum yield from their valuable cell lines.

Decoding RocketCell™'s Unique Formulation

RocketCell™ Cell Viability Enhancer represents a leap forward from conventional ROCK inhibitors. While typical ROCK inhibitors primarily focus on the suppression of apoptosis post-dissociation, RocketCell™ incorporates a proprietary blend of small molecules that stimulate cellular metabolism, facilitate cell-cycle re-entry, and bolster long-term growth performance after cells have undergone stress. This innovative approach is vital for enabling healthy, actively proliferating cultures, leading to better experimental outcomes.

John Huang, the CEO of TheWell Bioscience, states, “Researchers invest months developing valuable stem cell lines and organoids, yet routine handling can still result in substantial cell loss. Every viable cell matters. RocketCell™ Cell Viability Enhancer was designed to do more than improve survival — it helps cells recover faster, proliferate more efficiently, and generate healthier cultures.”

In validation studies, RocketCell™ showed promethean effects, with outcomes indicating a 70-80% increase in organoid recovery and cell viability. Induced pluripotent stem cells (iPSCs) benefited even more, showing a 7- to 8-fold boost in recovery and growth compared to standard methods of cell culture. These remarkable advancements are poised to revolutionize data reproducibility, significantly reduce costs, and minimize variability that often plagues scientific research.

Broad Applicability and Seamless Integration

One of the standout features of the RocketCell™ Cell Viability Enhancer is its versatility. Optimized for various applications, including induced pluripotent stem cells (iPSCs), neural stem cells (NSCs), organoids, and other dissociation-sensitive cultures, it can be effectively integrated into existing lab workflows without necessitating major protocol changes. From single-cell passaging to post-thaw recovery and organoid harvesting, RocketCell™ enhances both 2D and 3D cell cultures with ease.

The enhancer not only prevents apoptosis following dissociation but promotes sustained cellular recovery — boosting metabolic activity and enabling quicker transitions back to active growth. Internal validation has shown exceptional recovery rates, especially during the harvesting and replating phases. For instance, studies involving mouse intestinal and colon organoids demonstrated significant improvements in both recovery and expansion rates when RocketCell™ was utilized during these critical processes.

A Step Towards a Comprehensive Solution

The launch of RocketCell™ fits perfectly within TheWell Bioscience's growing array of xeno-free tools, which include RocketCell™ media, VitroGel® synthetic hydrogels, CytoGrow™ recombinant growth factors, VitroPrime™ cultureware, and Cyto3D® assays. Collectively, these products provide researchers with an integrated suite of solutions aimed at enhancing reproducibility and performance in cell biology research.

RocketCell™ Cell Viability Enhancer (1000X) is currently available in both 50 μL and 500 μL formats, catering to the varying needs of researchers. This launch represents an important milestone in cell viability technologies, paving the way for enhanced research capabilities in stem cell biology, regenerative medicine, drug development, and beyond. For additional resources, visit the product page on TheWell Bioscience website.

As the demand for innovative tools in the scientific community continues to rise, RocketCell™ is expected to become a valuable asset in achieving consistent and reliable results in cell culture, ultimately leading to significant advances in medical and scientific research.